- Home
- TACH vs CLLS Comparison
TACH vs CLLS Comparison
Compare TACH & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$3.46
Company Overview
Basic Information| Metric | TACH | CLLS |
|---|---|---|
| Founded | 2024 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 384.3M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | TACH | CLLS |
|---|---|---|
| Price | $10.29 | $3.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 58.6K | 41.3K |
| Earning Date | 01-01-0001 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $40.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $39.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.03 | $1.10 |
| 52 Week High | $10.38 | $5.48 |
Technical Indicators
Market Signals| Indicator | TACH | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 47.94 | 41.67 |
| Support Level | $10.26 | $3.41 |
| Resistance Level | $10.30 | $3.83 |
| Average True Range (ATR) | 0.02 | 0.21 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 14.29 | 20.00 |
Price Performance
Historical Comparison TACH
CLLS
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.